FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2887426516> ?p ?o ?g. }

• W2887426516 abstract "Abstract Background The increasing prevalence of Helicobacter pylori ( H. pylori) antimicrobial resistance, primarily for clarithromycin decreases the success of treatment. The aim of this study is to determine the local pattern of first‐line antimicrobials resistance and the eradication rate. Material and Methods Prospective cohort study of H. pylori infected patients (positive histological or cultural exams) treated at Centro Materno‐Infantil do Norte from January of 2013 to October of 2017. Susceptibility to 4 antibiotics: amoxicilin, metronidazole, clarithromycin, and levofloxacin were analyzed by E‐test (phenotypic resistance). The E‐test was chosen because it is simple and cost‐effective for routine susceptibility testing. Point mutations that confer clarithromycin resistance were surveyed (genotypic resistance). Eradication of H. pylori infection was defined by a negative urea breath test or fecal antigen 6‐8 weeks after the end of treatment. Results Of a total of 74 H. pylori infected patients, 16 were excluded because they had previous H. pylori treatment or severe systemic disease. Median age of infection cases was 15 years (3‐17 years). Eradication regimen used in all patients combined the use of 3 antibiotics (amoxicillin and metronidazole or clarithromycin) and proton pump inibhitor for 14 days and was tailored according antimicrobial susceptibility. 79.5% of the patients completed the treatment. The resistance rate for metronidazole and clarithromycin was 3.3% and 23.3%, respectively. There was no resistance for amoxicilin and levofloxacin. The rate of genotypic resistance to clarithromycin was 37.2%. The eradication rate was 97.8%. Conclusions The authors found a high resistance rate of H. pylori for clarithromycin in this northern portuguese pediatric center. This factor should determine a change in local current treatment, contraindicating the use of clarithromycin as a first‐line treatment for H. pylori infection in children. The high eradication rate maybe explained for the eradication treatment tailored according antimicrobial susceptibility." @default.
• W2887426516 created "2018-08-22" @default.
• W2887426516 creator A5007186003 @default.
• W2887426516 creator A5024540457 @default.
• W2887426516 creator A5031930104 @default.
• W2887426516 creator A5038969467 @default.
• W2887426516 creator A5041713019 @default.
• W2887426516 creator A5068064253 @default.
• W2887426516 date "2018-08-09" @default.
• W2887426516 modified "2023-10-01" @default.
• W2887426516 title "<i>Helicobacter pylori</i>antimicrobial resistance in a pediatric population" @default.
• W2887426516 cites W122758956 @default.
• W2887426516 cites W1598734559 @default.
• W2887426516 cites W1892590317 @default.
• W2887426516 cites W1931029373 @default.
• W2887426516 cites W1973566500 @default.
• W2887426516 cites W1984637828 @default.
• W2887426516 cites W1999824547 @default.
• W2887426516 cites W2022612531 @default.
• W2887426516 cites W2023842018 @default.
• W2887426516 cites W2024764245 @default.
• W2887426516 cites W2025026187 @default.
• W2887426516 cites W2031944634 @default.
• W2887426516 cites W2038965036 @default.
• W2887426516 cites W2047975024 @default.
• W2887426516 cites W2055557876 @default.
• W2887426516 cites W2070838208 @default.
• W2887426516 cites W2071007454 @default.
• W2887426516 cites W2081549710 @default.
• W2887426516 cites W2091987447 @default.
• W2887426516 cites W2111942462 @default.
• W2887426516 cites W2114582107 @default.
• W2887426516 cites W2119698116 @default.
• W2887426516 cites W2123943211 @default.
• W2887426516 cites W2127208126 @default.
• W2887426516 cites W2136077136 @default.
• W2887426516 cites W2136210283 @default.
• W2887426516 cites W2153165213 @default.
• W2887426516 cites W2153418611 @default.
• W2887426516 cites W2153517099 @default.
• W2887426516 cites W2157650397 @default.
• W2887426516 cites W2158819521 @default.
• W2887426516 cites W2168275222 @default.
• W2887426516 cites W2199203801 @default.
• W2887426516 cites W2604377831 @default.
• W2887426516 cites W4243464324 @default.
• W2887426516 cites W4250132006 @default.
• W2887426516 cites W4296118854 @default.
• W2887426516 doi "https://doi.org/10.1111/hel.12528" @default.
• W2887426516 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30091503" @default.
• W2887426516 hasPublicationYear "2018" @default.
• W2887426516 type Work @default.
• W2887426516 sameAs 2887426516 @default.
• W2887426516 citedByCount "24" @default.
• W2887426516 countsByYear W28874265162019 @default.
• W2887426516 countsByYear W28874265162020 @default.
• W2887426516 countsByYear W28874265162021 @default.
• W2887426516 countsByYear W28874265162022 @default.
• W2887426516 countsByYear W28874265162023 @default.
• W2887426516 crossrefType "journal-article" @default.
• W2887426516 hasAuthorship W2887426516A5007186003 @default.
• W2887426516 hasAuthorship W2887426516A5024540457 @default.
• W2887426516 hasAuthorship W2887426516A5031930104 @default.
• W2887426516 hasAuthorship W2887426516A5038969467 @default.
• W2887426516 hasAuthorship W2887426516A5041713019 @default.
• W2887426516 hasAuthorship W2887426516A5068064253 @default.
• W2887426516 hasConcept C114851261 @default.
• W2887426516 hasConcept C126322002 @default.
• W2887426516 hasConcept C2776409635 @default.
• W2887426516 hasConcept C2776962512 @default.
• W2887426516 hasConcept C2777396551 @default.
• W2887426516 hasConcept C2778715759 @default.
• W2887426516 hasConcept C2779708577 @default.
• W2887426516 hasConcept C2781276175 @default.
• W2887426516 hasConcept C2781413609 @default.
• W2887426516 hasConcept C501593827 @default.
• W2887426516 hasConcept C71924100 @default.
• W2887426516 hasConcept C86803240 @default.
• W2887426516 hasConcept C89423630 @default.
• W2887426516 hasConcept C90924648 @default.
• W2887426516 hasConcept C94665300 @default.
• W2887426516 hasConceptScore W2887426516C114851261 @default.
• W2887426516 hasConceptScore W2887426516C126322002 @default.
• W2887426516 hasConceptScore W2887426516C2776409635 @default.
• W2887426516 hasConceptScore W2887426516C2776962512 @default.
• W2887426516 hasConceptScore W2887426516C2777396551 @default.
• W2887426516 hasConceptScore W2887426516C2778715759 @default.
• W2887426516 hasConceptScore W2887426516C2779708577 @default.
• W2887426516 hasConceptScore W2887426516C2781276175 @default.
• W2887426516 hasConceptScore W2887426516C2781413609 @default.
• W2887426516 hasConceptScore W2887426516C501593827 @default.
• W2887426516 hasConceptScore W2887426516C71924100 @default.
• W2887426516 hasConceptScore W2887426516C86803240 @default.
• W2887426516 hasConceptScore W2887426516C89423630 @default.
• W2887426516 hasConceptScore W2887426516C90924648 @default.
• W2887426516 hasConceptScore W2887426516C94665300 @default.
• W2887426516 hasIssue "5" @default.
• W2887426516 hasLocation W28874265161 @default.
• W2887426516 hasLocation W28874265162 @default.
• W2887426516 hasOpenAccess W2887426516 @default.

• next